David M Lubman Selected Research

Proteome

12/2023	In-Depth Proteome Profiling of Small Extracellular Vesicles Isolated from Cancer Cell Lines and Patient Serum.
1/2019	Single Amino Acid Variant Discovery in Small Numbers of Cells.
7/2010	Quantitative proteomic profiling studies of pancreatic cancer stem cells.
3/2008	Humoral response profiling reveals pathways to prostate cancer progression.
8/2004	Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Lubman Research Topics

Disease

52	Neoplasms (Cancer) 03/2024 - 04/2002
23	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 07/2006
22	Fibrosis (Cirrhosis) 04/2023 - 04/2008
17	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 06/2014
11	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2003
10	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2004
10	Chronic Pancreatitis 04/2015 - 09/2006
9	Ovarian Neoplasms (Ovarian Cancer) 01/2015 - 04/2002
8	Adenocarcinoma 01/2017 - 08/2004
7	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 05/2010
6	Non-alcoholic Fatty Liver Disease 04/2023 - 01/2020
5	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 06/2014
5	Carcinoma (Carcinomatosis) 03/2009 - 04/2002
4	Liver Diseases (Liver Disease) 01/2021 - 06/2014
4	Melanoma (Melanoma, Malignant) 06/2011 - 11/2010
3	Cognitive Dysfunction 04/2024 - 01/2022
3	Disease Progression 03/2024 - 12/2008
2	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 10/2016 - 04/2008
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 05/2003
2	Pancreatitis 04/2014 - 06/2008
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2011 - 07/2007
2	Inflammation (Inflammations) 01/2011 - 03/2008
2	Endometrioid Carcinoma 04/2009 - 01/2006
2	Prostatic Neoplasms (Prostate Cancer) 03/2008 - 07/2003
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022
1	Neuroinflammatory Diseases 11/2022
1	Circulating Neoplastic Cells 10/2022
1	Fatty Liver 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Alcoholic Hepatitis 01/2021
1	Obesity 01/2021
1	Liver Neoplasms (Liver Cancer) 10/2020
1	Pediatric Crohn's disease 01/2019
1	Glioma (Gliomas) 02/2015
1	Ovarian Epithelial Carcinoma 01/2015
1	Carcinogenesis 04/2014

Drug/Important Bio-Agent (IBA)

64	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2002
44	Biomarkers (Surrogate Marker)IBA 03/2024 - 07/2003
31	Glycoproteins (Glycoprotein)IBA 04/2024 - 07/2006
16	LectinsIBA 10/2020 - 07/2006
15	GlycopeptidesIBA 04/2024 - 07/2006
15	Polysaccharides (Glycans)IBA 03/2024 - 07/2006
13	HaptoglobinsIBA 07/2022 - 05/2007
11	Peptides (Polypeptides)IBA 04/2023 - 09/2002
10	Blood Proteins (Serum Proteins)IBA 12/2023 - 01/2009
5	ProteomeIBA 12/2023 - 08/2004
5	AutoantibodiesIBA 01/2011 - 03/2008
4	Tumor Biomarkers (Tumor Markers)IBA 10/2022 - 08/2004
4	Amino Acids FDA Link 01/2020 - 12/2014
4	Collodion (Nitrocellulose)IBA 01/2010 - 07/2003
3	AntigensIBA 07/2022 - 03/2008
3	histidine-rich proteinsIBA 09/2012 - 04/2008
2	bis(p-chlorophenyl)acetic acid (DDA)IBA 04/2023 - 01/2022
2	antineoplaston A10 (A 10)IBA 11/2022 - 01/2017
2	TrypsinIBA 01/2022 - 01/2019
2	Ceruloplasmin (Ferroxidase)IBA 01/2022 - 06/2014
2	ApolipoproteinsIBA 01/2021 - 08/2007
2	CateninsIBA 10/2016 - 03/2008
2	Leucine (L-Leucine)FDA Link 01/2015 - 07/2013
2	HemopexinIBA 07/2013 - 05/2007
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 12/2011 - 10/2011
2	AntibodiesIBA 01/2011 - 01/2010
2	PhosphoproteinsIBA 06/2010 - 02/2006
2	AgglutininsIBA 05/2010 - 07/2006
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 05/2010 - 10/2008
2	Lamin Type A (Lamin A)IBA 03/2009 - 06/2007
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 05/2007 - 07/2006
1	lentil lectinIBA 04/2023
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 07/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020
1	acarboxyprothrombin (PIVKA)IBA 10/2020
1	Sepharose (Agarose)IBA 01/2020
1	EnzymesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	AcidsIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	AminesIBA 01/2018
1	Phenol (Carbolic Acid)FDA Link 01/2018
1	Gemcitabine FDA Link 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Epithelial Cell Adhesion MoleculeIBA 01/2017
1	AnnexinsIBA 01/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Fibronectins (Fibronectin)IBA 11/2015
1	TenascinIBA 02/2015
1	Transferrin (beta 2 Transferrin)IBA 12/2014

Therapy/Procedure

9	Therapeutics 03/2024 - 03/2004
3	Lasers (Laser) 06/2013 - 09/2002
2	Immunotherapy 01/2020 - 03/2012
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2016
2	Radiotherapy 04/2012 - 06/2011
1	Bariatric Surgery 01/2021
1	Chemoradiotherapy 01/2017
1	Chemoprevention 01/2016